Cassava Sciences | PTIE - DEBITO





DEBITO Cambiamento Data
Abbott USD 13.86B 919M 2025-12
Amgen USD 54.6B 17M 2025-12
Biogen USD 6.56B 275.1M 2026-03
Cara Therapeutics USD 0 0 2025-03
Cassava Sciences USD 0 0 2024-12
Eisai JPY 236.67B 49.14B 2025-09
Eli Lilly USD 42.5B 3.6M 2025-12
Geron USD 121.99M 76K 2025-12
J&J USD 47.93B 2.14B 2025-12
Merck USD 49.34B 7.97B 2025-12
Novartis USD 47B 11.62B 2026-03
Novavax USD 233.31M 4.23M 2024-09
Pfizer USD 63.73B 231M 2026-03
Roche Holding CHF 33.03B 1.41B 2025-06